2018 American Transplant Congress

June 2-6, 2018 in Seattle, WA

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Introduction of Direct Acting Antivirals for HCV: Fewer Kidney Discards but a Long Way to Go

T. Alhamad,¹ R. Thakkar,¹ D. Brennan,² J. Lappin,³ B. Kaplan,³ A. Malone,¹ V. Hicks,¹ J. Wellen,¹ K. Lentine.⁴
Investigating the Variability of Fluid Resuscitation during Laparoscopic Donor Nephrectomy

A. Williams,¹ S. Kumar,² R. Sung,¹ K. Woodside,¹ M. Englesbe,¹ M. Alameddine,¹ S. Waits.¹
Investigation of Lower Treatment Failure Rate Seen among Black Kidney Recipients on LCP-Tacrolimus vs. IR-Tacrolimus: Subgroup Analyses of Two Phase 3 Trials

T. Sparkes,¹ B. Masters,¹ C. Staino,² S. Patel,² M. Cooper.³
Involvement of Additional Surgeons in Robot Assisted Kidney Transplantation Does Not Affect Surgical Outcomes, in the Context of a Structured Robotic Surgery Program. Results from a CUSUM Analysis

F. Gheza,¹ C. Di Bella,¹ P. Giulianotti,¹ J. Oberholzer,² E. Benedetti,¹ I. Tzvetanov.¹
Involvement of Aldehyde Dehydrogenase 2 (ALDH2) in Fatty Liver Graft Protection Mechanisms against Cold Ischemic Injury

A. Panisello-Rosello,¹ A. Lopez,² C. Castro,² S. Bellogi,¹ E. Folch-Puy,¹ A. Rolo,³ C. Palmeira,³ R. Adam, J. Roselló-Catafau.
Involvement of PD-L1 Upregulation in Anti-A/B Antibody-Induced Graft Accommodation: Reduction of CD4 T Cell Allo-Response against Graft HLA Class II DR

K. Iwasaki,¹ Y. Miwa,¹ H. Hamana,³ H. Kishi,³ A. Muraguchi,³ K. Uchida,¹ T. Kobayashi.²
Is Age a Potential Barrier to Pursuing Living Donor Kidney Transplant (LDKT)?

A. Raissi, N. Edwards, Y. Liao, D. Belenko, N. Singh, M. Khalid, D. Toews, I. Mucsi.
Is BMI > 35 a Barrier to Kidney Transplantation?

D. Walczak, E. Benedetti, C. Ryan.
Is It Better Choice to Perform Kidney Transplantation for Elderly CKD Patients?

R. Imamura,¹ K. Tsutahara,² K. Yamanaka,³ M. Kawamura,¹ S. Nakazawa,¹ T. Kato,¹ T. Abe,¹ H. Kishikawa,³ N. Ichimaru,⁴ K. Nishimura,³ S. Yamaguchi,² N. Nonomura.¹
Is KDPI Valid for Hepatitis C Aviremic Kidneys?

L. Sibulesky,¹ C. Kling,¹ C. Blosser,² C. Johnson,² A. Limaye,² R. Bakthavatsalam,¹ N. Leca,² J. Perkins.¹

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z